Stephanie Bragg, M.S., joined Statistics Collaborative, Inc. (SCI) in 2015. She is a member of the Society for Clinical Trials.
At SCI, Ms. Bragg has contributed to projects related to rare neuromuscular disorders and worked with clinical trials in several disease areas, including leukemia, renal cell carcinoma, Alzheimer’s disease, glioblastoma, cardiovascular disease, gonorrhea, and non-Hodgkin’s lymphoma. As a biostatistician on these studies, she performs statistical analyses and sample size calculations, programs datasets, generates graphs, tables, and listings, validates program code, and assists in the writing of study reports.
Ms. Bragg has served as the reporting statistician and project manager for trials evaluating treatments for melanoma, bladder cancer, overactive bladder, pulmonary hypertension due to chronic obstructive pulmonary disease, sickle cell disease, and type 2 diabetes. As a project manager and reporting statistician, Ms. Bragg has served as the main contact for clients. She has coordinated and managed programming for a final analysis, developed table shells, reviewed DMC charters, written statistical analysis plans and statistical sections of study protocols, presented interim monitoring reports to DMCs, and managed teams of programming and research staff.
She received her B.S. summa cum laude in Mathematics (concentration in Applied Mathematics) and Economics from the College of William and Mary (2013) and her M.S. in Mathematics and Statistics from Georgetown University (2014).
To contact SCI about a potential project, please call us at 202.247.9700 or click below.
Statistics Collaborative is experencing a business interruption due to circumstances beyond our control. Please call our main company phone number for details and updates.